| III-58 Theodoros Papathanasiou Population pharmacokinetics of belantamab mafodotin in relapsed or refractory multiple myeloma patients with severe renal impairment Thursday 10:15-11:45 |
| III-58 Theodoros Papathanasiou Population pharmacokinetics of belantamab mafodotin in relapsed or refractory multiple myeloma patients with severe renal impairment Thursday 10:15-11:45 |